Awarded
Eculizumab 300 mg in 30 ml Konzentrat Infusionslösungskonzentrat St a 30 ml (mit aHUS Indikation)
- Buyer
- PBMG eG
- Winners
- Amgen GmbH
- Contract value
- no value published
- Bids received
- 1
- Published
- 27 Feb 2026
- Awarded
- 29 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2027stated
- Region
- Hamburg (DE600)